Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Mayo Clin Proc. 2018 Aug;93(8):991–1008. doi: 10.1016/j.mayocp.2018.05.019

Table 4b).

Summary of response rates to various treatments in C3G

Response Steroid monotherapy
(n=12)
Mycophenolate mofetil
(n=24)
Eculizumab
(n=7)
Calcineurin inhibitors
(n=7)
Rituximab
(n=2)
Median Duration (range) 2.5months(0.2–80.1) 9.6 months (Range; 1–96.2) 8.5 months (range: 1.6–26.7) 17.4months (range: 3.1–50.9) 0.75 months (0.5–1.0)
CR 2 1 2 0 0
PR 3 2 1 1 1
Responder 1 0 1 0 0
NR 4 15 (of which 3 reached ESRD) 3 (of which 2 reached ESRD) 6 (of which 1 reached ESRD) 0
SD 1 4 0 0 1
Lost to follow-up 1 2 0 0 0

Abbreviations: CR, complete response; PR, partial response; NR, no response; SD, stable disease.